Building pharmaceutical systems that can withstand scrutiny.
Vishal Chakravarty is Chief Executive Officer of NovaPharm Healthcare Ltd and a director of the active UK company. He leads corporate strategy, operating-model design and the development of NovaPharm's digital pharmaceutical ecosystem.
His work focuses on UK-EU pharmaceutical market access, MHRA-aware parallel import frameworks, Good Distribution Practice, supply-chain resilience and the practical connection between regulatory evidence and commercial execution.
Vishal's published perspectives examine how post-Brexit regulatory divergence changes market access, distribution decisions and compliance responsibilities for pharmaceutical operators.